Key statistics
On Friday, Faron Pharmaceuticals Oy (4FR:FRA) closed at 2.56, -26.77% below its 52-week high of 3.49, set on Dec 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.56 |
---|---|
High | 2.56 |
Low | 2.56 |
Bid | 2.55 |
Offer | 2.63 |
Previous close | 2.53 |
Average volume | 272.00 |
---|---|
Shares outstanding | 104.62m |
Free float | 71.27m |
P/E (TTM) | -- |
Market cap | 224.94m GBP |
EPS (TTM) | -0.3183 GBP |
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Announcements
- Grant of options
- Faron 2024 Half-Year Financial Results
- FDA Grants Fast Track Designation for Bexmarilimab
- Notice of Half-Year Financial Results
- Traumakine Research Collaboration and DoD Grant
- Appointment of Chief Financial Officer
- Grant of options
- Faron Appoints Dr. Petri Bono as new CMO
- Faron Announces Positive FDA Feedback
- Update on settlement
More ▼